TNKASE (tenecteplase)
THROMBOLYTIC AGENTS · ACUTE MYOCARDIAL INFARCTION ·+1
GENENTECH
Drug class
Thrombolytic Agents
Thrombolytic agents, also known as fibrinolytic agents, are a therapeutic class of medications designed to rapidly dissolve pathological intravascular blood clots. Read more about Thrombolytic Agents
4 drugs in this class 2 manufacturers
Drugs in Thrombolytic Agents
ACTIVASE (alteplase)
THROMBOLYTIC AGENTS · ACUTE MYOCARDIAL INFARCTION ·+2
GENENTECH
DEFITELIO (defibrotide sodium)
THROMBOLYTIC AGENTS · HEPATIC VENO-OCCLUSIVE DISEASE
JAZZ PHARMACEUT
TNKASE (tenecteplase)
THROMBOLYTIC AGENTS · ACUTE MYOCARDIAL INFARCTION ·+1
GENENTECH
Filter & compare in the drug finder →
Opens the drug finder with Thrombolytic Agents preselected. Add indication or manufacturer filters there.
Thrombolytic agents, also known as fibrinolytic agents, are a therapeutic class of medications designed to rapidly dissolve pathological intravascular blood clots.
They function primarily as plasminogen activators that convert the inactive proenzyme plasminogen into plasmin, an active enzyme that degrades the fibrin meshwork stabilizing a thrombus.
This class is utilized in acute, time-critical cardiovascular and thromboembolic emergencies to restore vascular perfusion and limit tissue necrosis.
Primary clinical indications include acute ischemic stroke, ST-segment elevation myocardial infarction (STEMI), and hemodynamically unstable pulmonary embolism.
-
nih.gov
Thrombolytic agents, also known as fibrinolytic agents, are a therapeutic class of medications designed to rapidly dissolve pathological intravascular blood clots They function primarily as plasminogen activators that convert the inactive proenzyme plasminogen into plasmin, an active enzyme that degrades the fibrin meshwork stabilizing a thrombus This class is utilized in acute, time-critical cardiovascular and thromboembolic emergencies to restore vascular perfusion and limit tissue necrosis
-
nih.gov
Thrombolytic agents, also known as fibrinolytic agents, are a therapeutic class of medications designed to rapidly dissolve pathological intravascular blood clots This class is utilized in acute, time-critical cardiovascular and thromboembolic emergencies to restore vascular perfusion and limit tissue necrosis
-
nih.gov
They function primarily as plasminogen activators that convert the inactive proenzyme plasminogen into plasmin, an active enzyme that degrades the fibrin meshwork stabilizing a thrombus Primary clinical indications include acute ischemic stroke, ST-segment elevation myocardial infarction (STEMI), and hemodynamically unstable pulmonary embolism
-
nih.gov
Primary clinical indications include acute ischemic stroke, ST-segment elevation myocardial infarction (STEMI), and hemodynamically unstable pulmonary embolism
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.